Trading Members of the Exchange are hereby informed that effective from August 17 2026 the Equity Shares of Molbio Diagnostics Ltd (Scrip Code: 544866) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no 20260814- dated August 14 2026.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
